
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Brilliant and Gleaming: Excellence and Skincare Practices - 2
10 Demonstrated Tips to Expand Your New Android Cell phone: A Thorough Aide - 3
The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior - 4
African nations push to recognize crimes of colonialism in Algeria - 5
Defeating An inability to embrace success in Scholarly world: Individual Victories
PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
Herzog, German Chancellor Merz discuss final Gaza hostage, Arrow 3 exchange in Jerusalem
UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
Shrewd Home Gadgets to Save Energy
Palestinians forced from West Bank refugee camps left in limbo as Israeli demolitions go on
Ukrainian man arrested in Germany on suspicion of spying for Russia
Dirty soda started as a Mormon alternative to booze. Now it's everywhere.
Mars orbiter sees 'butterfly' crater spread its wings on the Red Planet
Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy













